Dr. Lal PathLabs Limited (BOM:539524)

Dr. Lal PathLabs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 26, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	231,233	206,551	187,931	151,339	215,706	223,265
Market Cap Growth	9.91%	9.91%	24.18%	-29.84%	-3.39%	93.43%
Enterprise Value	221,504	197,605	182,294	149,438	206,326	216,093
Last Close Price	2771.25	2472.90	2239.81	1791.48	2541.26	2628.75
PE Ratio	47.47	42.40	52.53	63.36	62.55	76.56
PS Ratio	9.39	8.39	8.44	7.50	10.33	14.12
PB Ratio	10.48	9.36	9.97	8.90	14.03	17.50
P/TBV Ratio	16.83	15.04	18.85	19.91	39.39	20.29
P/FCF Ratio	44.08	39.37	38.82	36.08	61.18	61.58
P/OCF Ratio	40.65	36.31	35.10	33.19	48.29	56.08
EV/Sales Ratio	9.00	8.03	8.19	7.41	9.88	13.67
EV/EBITDA Ratio	31.93	30.03	32.14	33.87	39.77	54.18
EV/EBIT Ratio	39.60	35.33	38.94	43.93	45.38	60.06
EV/FCF Ratio	42.22	37.67	37.65	35.62	58.52	59.60
Debt / Equity Ratio	0.07	0.07	0.13	0.25	0.35	0.12
Debt / EBITDA Ratio	0.23	0.23	0.41	0.87	0.96	0.35
Debt / FCF Ratio	0.30	0.30	0.51	1.00	1.51	0.42
Asset Turnover	0.95	0.95	0.92	0.85	1.04	1.04
Inventory Turnover	28.25	28.25	26.65	20.66	19.34	14.16
Quick Ratio	3.20	3.20	2.27	1.93	1.57	3.92
Current Ratio	3.39	3.39	2.43	2.07	1.75	4.18
Return on Equity (ROE)	24.06%	24.06%	20.21%	14.90%	24.90%	25.45%
Return on Assets (ROA)	13.51%	13.51%	12.09%	8.98%	14.18%	14.82%
Return on Capital (ROIC)	15.55%	15.55%	13.76%	10.15%	16.26%	17.23%
Return on Capital Employed (ROCE)	24.20%	24.20%	23.50%	17.80%	24.60%	25.90%
Earnings Yield	2.11%	2.36%	1.90%	1.58%	1.60%	1.31%
FCF Yield	2.27%	2.54%	2.58%	2.77%	1.64%	1.62%
Dividend Yield	0.83%	0.97%	1.07%	0.67%	0.47%	0.76%
Payout Ratio	41.03%	41.03%	55.76%	41.62%	33.83%	34.11%
Buyback Yield / Dilution	-0.22%	-0.22%	-0.14%	-0.21%	-0.24%	-0.23%
Total Shareholder Return	0.61%	0.75%	0.93%	0.46%	0.23%	0.53%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.